Berry D L, Dodd M J, Hinds P S, Ferrell B R
Department of Biobehavioral Nursing and Health Systems, University of Washington, Seattle, USA.
Oncol Nurs Forum. 1996 Apr;23(3):507-12.
PURPOSE/OBJECTIVES: To review the issues related to informed consent in a clinical cancer care setting and suggest strategies to improve the informed consent process.
Published books, journal articles, and clinical research experience.
Clinicians and researchers are ethically obligated to maintain the informed consent process when treating participants in clinical cancer research. Nurse clinicians, clinical trial nurses, and nurse researchers often encounter dilemmas while ensuring proper informed consent. Nurses involved in pediatric cancer care must address specific consent issues relevant to children and youth.
Informed consent does not end with a patient's signature on a form. Establishing and maintaining informed consent is a multidisciplinary effort in cancer clinical trials. Nurses can improve the informed consent process by ensuring adequate time for patient consideration and understanding and by reassessing consent during the study.
Clinical trial nurses and nurse investigators in both adult and pediatric oncology have a duty and obligation to maintain continued informed consent throughout a study and to be involved in all aspects of study planning and implementation.
目的/目标:回顾临床癌症护理环境中与知情同意相关的问题,并提出改善知情同意流程的策略。
已出版的书籍、期刊文章及临床研究经验。
临床医生和研究人员在治疗临床癌症研究参与者时,在伦理上有义务维持知情同意流程。护士临床医生、临床试验护士和护士研究人员在确保适当的知情同意时经常遇到困境。参与儿童癌症护理的护士必须处理与儿童和青少年相关的特定同意问题。
知情同意并非以患者在表格上签字而结束。在癌症临床试验中,建立和维持知情同意是一项多学科的工作。护士可以通过确保患者有足够的时间进行考虑和理解,并在研究期间重新评估同意情况来改善知情同意流程。
成人和儿科肿瘤学的临床试验护士和护士研究人员有责任和义务在整个研究过程中维持持续的知情同意,并参与研究规划和实施的各个方面。